Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2125]

ESMO 2017: Mature results favour pembrolizumab as second-line treatment for bladder cancer

ESMO 2017: Mature results favour pembrolizumab as second-line treatment for bladder cancer

ESMO 2017: Combination immunotherapy in second/third line extends mesothelioma survival to 15 months

ESMO 2017: Combination immunotherapy in second/third line extends mesothelioma survival to 15 months

Human papillomavirus 16 infections may pose variable cancer risk

Human papillomavirus 16 infections may pose variable cancer risk

The STING of death in T cells

The STING of death in T cells

Vaccine to prevent most cervical cancers shows long-term effectiveness

Vaccine to prevent most cervical cancers shows long-term effectiveness

Outreach interventions improve colorectal cancer screening

Outreach interventions improve colorectal cancer screening

ESMO 2017: Study in early stage breast cancer shows that even small tumours can be aggressive

ESMO 2017: Study in early stage breast cancer shows that even small tumours can be aggressive

Breast cancer patients on opioids less likely to stick to vital treatment

Breast cancer patients on opioids less likely to stick to vital treatment

Key factor identified in gene silencing

Key factor identified in gene silencing

Combination of conventional and new drugs enhances tumour cell death

Combination of conventional and new drugs enhances tumour cell death

More from ecancer